Atopic dermatitis (AD) is one of the most common inflammatory diseases in children and is characterized by intense pruritis (itch) and abnormal skin. [1] [2] [3] AD is an early indicator of subsequent atopic diseases, with roughly 60% of children with AD later having airway hyperresponsiveness. [4] [5] [6] The pathogenesis of AD involves impaired keratinocyte differentiation and diminished skin barrier function, resulting in dry (xerotic) skin, increased susceptibility to bacterial and viral infections, and augmented percutaneous exposure to environmental allergens. 3, 7 The T H 2-type cytokine IL-4 has been shown to affect keratinocyte differentiation. [7] [8] [9] IL-4 is a pleiotropic cytokine secreted by activated T lymphocytes and innate immune cells acting through a receptor on hematopoietic cells composed of the IL-4 receptor (IL-4R) a and gc receptor (type I IL-4R). 10, 11 Keratinocytes and other nonhematopoietic cells do not express gc receptors but can respond to IL-4 through the type II IL-4R composed of IL-4Ra and IL-13 receptor a1.
12 IL-4 binding to either receptor mediates the phosphorylation and dimerization of signal transducer and activator of transcription 6 (STAT6), regulating transcriptional activation of genes in target cells. 9 Keratinocytes exposed to IL-4 exhibit reduced expression of epidermal differentiation complex genes, 13 decreased expression of defensins, 3 altered expression of keratins, 14 and increased production of the chemokine CCL26 (eotaxin 3). 15 IL-4 is an important target in patients, and in clinical trials of subjects with moderate-to-severe AD, disease scores improved after anti-IL-4Ra human antagonist antibody treatment. 16 However, there is still little known regarding the consequences of IL-4 signaling on keratinocyte differentiation and barrier protection. The current study defines the global changes induced by IL-4 on gene expression in human keratinocytes (HKs) through bioinformatics analysis of gene expression after high-throughput analysis (RNA sequencing [RNA-Seq] ). This analysis identified a wound-healing pathway, including expression of fibronectin by keratinocytes, which is repressed by IL-4 treatment and likely contributes to pathology in patients with AD. Moreover, modulating this pathway in an in vivo model improved wound repair.
METHODS Mice
Female BALB/C and C57BL/6 mice were purchased from Harlan Bioscience (Indianapolis, Ind). The generation of Stat6VT transgenic mice was previously described. 17 These mice express the human STAT6 gene with V547 and T548 mutated to alanine under transcriptional control of the CD2 locus control region. IL-4-deficient mice (Il4 2/2 ) were purchased from the Jackson Laboratory (Bar Harbor, Me) and mated to Stat6VT transgenic mice. Stat6 2/2 mice were generated and backcrossed for at least 10 generations to BALB/c mice, as described previously. 18 Mouse ears were punched with a 2-mm punch (Kent Scientific, Torrington, Conn) to determine the in vivo wound-healing response. In some experiments mice were treated for 2 days with ointment containing BSA (Promega, Madison, Wis) or fibronectin purified from human plasma (Sigma, St Louis, Mo). Wild-type (WT) and Stat6 2/2 mice were treated with the vitamin D analogue MC903 (Calcipotriol, Sigma), as previously described, to determine the wound response in an induced model of AD-like disease. 19 MC903 was dissolved in 100% ethanol and topically applied on mouse ears (2 nmol in 25 mL per ear) for 5 days. Ethanol alone was used as a vehicle control. Ears were punched at day 6 after treatment. Mice were maintained in pathogen-free conditions, and all studies were approved by the Animal Care and Use Committee of the Indiana University School of Medicine.
Keratinocyte cell culture
Primary HKs were isolated from excised foreskin tissue, as previously described, 20 and washed with antibiotics. The tissue was minced, and the individual cells were released from the tissue by using trypsin digestion. Keratinocytes and fibroblasts were separated by means of differential resistance to treatment with EDTA. Isolated cells were grown in EpiLife Complete Medium (Life Technologies, Grand Island, NY) with HK growth supplement (Life Technologies) and 1000 U of penicillin-streptomycin (Roche, Mannheim, Germany) and grown as unmanipulated cultures or immortalized by the expression of human telomerase reverse transcriptase. 21 HKs were treated with 2 mmol/L CaCl 2 every other day to stimulate keratinocyte differentiation. HKs were stimulated with 20 ng/mL or the indicated concentration of recombinant human IL-4 (R&D Systems, Minneapolis, Minn) or IL-13 (PeproTech, Rocky Hills, NJ). All HK samples were deidentified, and the institutional review board of the Indiana University School of Medicine certified these studies as exempt.
Histologic and immunofluorescence analysis
Ear tissue was fixed with 10% formalin for 24 hours. Routine histologic techniques were used to paraffin embed the ears, and 5-mm sections were stained with hematoxylin and eosin or Masson trichrome. Ki-67 expression was analyzed by means of immunofluorescence with rabbit anti-human Ki-67 (SP6) antibody and anti-rabbit 488 nm. Quantitative digital morphometric analysis of the percentage of re-epithelialization was measured by using Image J 1.43u (National Institutes of Health, Bethesda, Md). The percentage of re-epithelialization was calculated by dividing the total pixel length of the lesion visualized at days 3 or 6 after wounding by the pixel length of lesions with incomplete re-epithelialization.
In vitro wound assay and live cell imaging
Normal HKs were cultured at 100% confluence in plates covered or not with 1 mg/mL BSA (Promega) or fibronectin from human plasma (Sigma-Aldrich). HKs were cultured with calcium chloride alone in EpiLife Complete Medium and stimulated with 20 ng/mL recombinant human IL-4, as indicated. At days 2 or 5, a cell-free area was created by scratching the monolayer with a 200-mL pipette tip. Time-lapse photography was performed on an automated time-lapse imaging system (Biostation IM-Q; Nikon Instruments, Tokyo, Japan) every 2 minutes in an environmentally controlled chamber (5% CO 2 , 378C, 3.2 minutes) fitted with the 203 NA 0.8 lens and a DS-Qi1 CCD camera. Photoshop (Adobe, San Jose, Calif) software platforms were used to export movies.
Organotypic skin equivalent
In vitro skin equivalents were constructed by using normal primary fibroblasts and keratinocytes isolated from human neonatal foreskin, as previously described. 22 Skin equivalents were grown at 358C in an air incubator for 7 to 10 days, and fresh medium was added every 2 days.
Cell isolation and flow cytometry
Epidermis was separated from dermis after enzymatic treatment with 400 mg/mL Liberase (Roche) for 90 minutes at 378C. Total cells were further isolated from the epidermis by using the gentleMacs dissociator (Miltenyi Biotech, Bergisch Gladbach, Germany), according to the manufacturer's instructions. For detection of Stat6VT expression, splenocytes and total epidermal and dermal cell suspensions were preincubated with Fc-block (BD PharMingen, San Jose, Calif) for 10 minutes at 48C before incubation with anti-CD45, anti-CD3, anti-CD4, anti-CD8, and anti-CD19 for 30 minutes at 48C. HKs were harvested and incubated with Human TruStain FcX (BioLegend, San Diego, Calif) for 10 minutes at 48C. The cells were fixed and permeabilized for intracellular staining with phospho-STAT6 Alexa Fluor 488 (BD PharMingen) or anti-Flag APC (DYKDDDDK tag epitope, BioLegend) antibody before analysis by means of flow cytometry (Attune Acoustic Focusing Cytometer), as previously described. 23 The results were analyzed with FlowJo software (Ashland, Ore).
ELISA
CCL26 levels were measured in the supernatants of HKs by using the human Quantikine ELISA Kit (R&D Systems, Minneapolis, Min). Fibronectin levels were measured in single-cell suspension lysates isolated from the dermis and epidermis, as described above. Fibronectin levels were measured by using a mouse ELISA kit (Abcam, Cambridge, United Kingdom), according to the manufacturer's instructions.
Quantitative RT-PCR
Total RNA was isolated from cells and reverse transcribed, according to the manufacturer's instructions (Invitrogen Life Technologies, Carlsbad, Calif). Quantitative PCR was performed with TaqMan Fast Universal PCR Master Mix and commercially available primers (Applied Biosystems, Foster City, Calif). RNA was normalized to expression levels of b 2 -microglobulin, and relative expression was calculated with the 2 2DDCt method.
Statistical analysis
Statistical analysis was determined by using the unpaired Student t test or ANOVA, followed by the Tukey test for multiple comparisons, and a P value of less than .05 was considered significant.
Alignment of RNA-Seq reads to human genome
Total RNA was isolated from immortalized HKs cultured under conditions indicated above by using TRIzol reagent. RNA samples were purified with the RNase-Free DNAse Kit (Qiagen, Hilden, Germany). RNA-Seq libraries were generated by Otogenetics using the HiSeq 2000 sequencing instrument with 20 million paired-end 100 nucleotide reads per sample, with biological duplicates for each condition and results displayed as average samples. The percentage of mapped reads (50% to 56% of sequences) represented 203 nucleotide coverage of the estimated transcriptome. Bioinformatics analysis was performed by the Bioinformatics Core at Indiana University School of Medicine. Short reads (fastq files) from each sample were independently aligned to human reference genome hg19 by using tophat (version 2.1.0), with default parameters and known transcriptomes. Alignment results were filtered by using bamutils v0.5.0 to remove reads with multiple mappings. Statistics data of the resulting alignment files were created with samtools (version 0.1.18) and bamutils (version 0.5.0). The counts of aligned reads mapping to known genes were calculated by using bamutils (version 0.5.0). EdgeR (version 2.11) was used for differential expression analysis. RNA-Seq data files were submitted to the Gene Expression Omnibus (accession no. GSE59275). Gene ontology analysis was performed with DAVID Bioinformatics resources, 24 Venn diagram analyses were generated with Venny (http://bioinfogp.cnb.csic.es), and heat maps were created with the MultiExperiment Viewer (http://www.tm4.org/).
RESULTS

IL-4 responses in HKs
To begin to define keratinocyte responses to IL-4, we characterized the expression of IL-4 signaling components. Immortalized HKs were cultured for 5 days in calcium chloride and demonstrated increased filaggrin (FLG) expression as an indicator of differentiation. Differentiated HKs exhibited greater expression of STAT6, IL4R, and the inhibitory IL13RA2 at day 5, contrasting largely unchanged expression of IL13RA1 during the differentiation period (see Fig E1, The parallels between these responses and those previously published for isolated keratinocytes and skin tissue validated this approach for further study. 8, 9, [25] [26] [27] To broadly determine IL-4-stimulated transcriptional changes in HKs, we performed RNA-Seq analysis. At day 2 of culture, HKs were incubated in the presence or absence of IL-4 for 3 or 24 hours. After 3 hours, IL-4 stimulation resulted in at least a 2-fold change in the expression of 47 genes when compared with cells cultured with media alone (Fig 1, A and B) . After 24 hours, IL-4 stimulation resulted in a differential expression of 1164 genes (Fig 1, A and B) . The genes most differentially regulated at both time points are indicated by the heat map in Fig 1, C. Among the transcripts increased at 24 hours that were classified by using DAVID analysis, 39 were associated with regulation of cell death, 33 were involved with immune response and cytokine-receptor interaction, and 31 were involved with cellcycle regulation (Fig 1, D) . Transcripts for proteins involved with cell adhesion, response to organic substances, and intracellular transport and secretion were the largest functional categories of genes with expression decreased by IL-4.
Three-dimensional cultures (human skin equivalents) were treated with IL-4 for 24 hours before testing the expression of 7 IL-4-induced genes to extend these findings. Treatment with IL-4 resulted in a significant increase in CCL26, CA2, CISH, and SER-PINB4 (see Fig E2, A, in this article's Online Repository at www. jacionline.org). Additionally, the effects of IL-4 on HK monolayer gene expression increased in a dose-dependent manner (see Fig E2, B) . Like IL-4, IL-13 alters gene expression in keratinocytes. 12, 14 HKs were differentiated and stimulated with IL-4 or IL-13 for 5 days before analyzing the expression of genes to determine whether IL-4 and IL-13 have similar function in regulating HK gene expression. IL-13 decreased FLG, IVL, LOR, and fibronectin 1 (FN1) similarly to IL-4 (see Fig E2, C) . IL-13 also resulted in a comparable increase in SERPINB3 and SERPINB4 expression but only a partial increase in CCL26 and CISH expression when compared with IL-4. Collectively, these data showed that acute stimulation of keratinocytes with IL-4 alters the expression of genes encoding proteins with diverse functions that could ultimately influence local inflammatory responses, alter cell proliferation and survival, and favor loss of cell adhesion.
RNA-Seq analysis of keratinocytes chronically stimulated with IL-4
As shown in Fig E1, D, exposure of keratinocytes to calcium chloride for 5 days resulted in altered expression of differentiation-related genes. Thus to determine whether IL-4 modifies genes expressed by keratinocytes in later phases of differentiation, we performed RNA-Seq analysis of HKs differentiated for 5 days and incubated with or without IL-4 before comparing the results with HKs cultured for 2 days. HKs differentiated for 5 days exhibited differential expression of 1724 genes when compared with HKs at day 2, with IL-4 altering expression of 303 genes (Fig 2, A and B) . The expression pattern for a subset of genes in IL-4-stimulated HKs at day 5 of culture was similar to the expression pattern in control HKs at day 2 (Fig 2, C) . IL-4 also increased the expression of a set of genes compared with unstimulated HKs at either time point (Fig 2, C) . AVenn diagram shows the 1166 genes increased and 558 genes decreased during HK differentiation J ALLERGY CLIN IMMUNOL VOLUME 139, NUMBER 1 (Fig 2, B) . IL-4 attenuated differentiation-induced changes in gene expression of 71 genes (45 were decreased and 26 were increased; Fig 2, B) . Moreover, IL-4 further augmented the expression of 4 genes and decreased the expression of 1 gene in calciumdifferentiated HKs (Fig 2, B) . We also observed that IL-4 increased expression of 200 genes and decreased expression of 27 genes in HKs that were not differentially expressed during differentiation (Fig 2, B) . A gene ontology analysis of IL-4-regulated genes showed that chronic exposure to IL-4 increased transcription of 25 genes involved with cell adhesion and 17 genes related to cell projection. IL-4 decreased transcription of 9 genes involved with wound healing and 8 genes involved in host defense (Fig 2, D) .
IL-4 impairs the keratinocyte wound-healing response
As noted above, a subset of genes regulated by IL-4 affects the wound repair process. This observation is consistent with diminished wound repair in children who show signs of increased atopy 28 and with the diminished recovery of transepidermal water loss after injury in Stat6VT transgenic mice, a model of allergic skin inflammation. 9, 27 To investigate whether IL-4-induced changes in the wound-healing subset of genes alter functional activity of HKs, we assayed for wound-healing capacity in culture. HKs were differentiated for 2 or 5 days and cultured in the presence or absence of IL-4. Scratches were made in the confluent monolayer to simulate wounding, and wound closure was monitored over 48 hours. Time-lapse analysis showed that differentiated keratinocytes migrate toward the wound area within 24 hours and partially close the wound space (see Fig E3, A, in this article's Online Repository at www.jacionline.org). Proliferative cells were observed in the area adjacent to the wound edge (see Video E1 in this article's Online Repository at www. jacionline.org), whereas cells at the edge guided the movement of neighboring cells. In contrast, IL-4-stimulated keratinocytes did not migrate toward the wound edge and exhibited significantly separated by dashed lines). A, Representation of ear punch. B and C, Visualization of histologic sections from distal areas from lesion (Fig 4, B) and lesion re-epithelialization and wound closure (Fig 4, C) . J ALLERGY CLIN IMMUNOL VOLUME 139, NUMBER 1 less wound closure in both cultures when compared with the control cells (see Fig E3, B) . Because IL-4 decreases the potential wound-healing response of HKs at days 2 and 5 of differentiation, we used RNA-Seq analysis to better define a target gene involved in reduced wounding at both time points. Thus, as we observed, at days 2 and 5 of differentiation, IL-4-treated HKs exhibited reduced FN1 expression (see Fig E3,  C) . Keratinocytes cultured with increasing concentrations of IL-4 exhibited reduced levels of FN1 mRNA (Fig 3, A) . These cells also exhibited reduced fibronectin production (Fig 3, B) and decreased FN1 mRNA expression 3 hours after scratching of monolayers in the in vitro wound-healing assay (Fig 3, C) .
To further assess whether fibronectin potentiates woundhealing response in IL-4-treated HKs, cells were differentiated for 5 days in control plates, BSA-coated plates, or fibronectincoated plates and cultured in the presence or absence of IL-4. A quantitative analysis showed that IL-4-treated HKs cultured on a fibronectin substratum exhibited a significant increase in wound closure when compared with HKs cultured on control or BSA substratum with IL-4 (Fig 3, D and E) . Collectively, IL-4 potently inhibits the wound-healing capacity of keratinocytes by inhibiting fibronectin production.
Impaired skin wound-healing response in models of AD-like disease
Because IL-4 decreased keratinocyte wound closure, mice with spontaneous development of AD-like lesions (Stat6VT mice) were used to test the influence of the allergic environment on in vivo (Fig 5, A) or in nonlesional skin in WT and Stat6VT mice and mice with spontaneous lesions (Fig 5, B) . C, Fibronectin levels were measured by using ELISA in dermis and epidermis in WT and Stat6VT mice 24 hours after wounding punch. Fold change was determined over intact skin (0 hours). D and E, Ear representation (Fig 5, D) and lesions monitored by using hematoxylin and eosin staining in ears of WT and Stat6VT at day 3 after wounding (Fig 5, E ; open wound size [w] measured by means of morphometry are indicated by dotted black lines). F and G, Morphometric analysis of percentage of wound closure at day 3 after punch in WT and Stat6VT mice treated with ointment containing BSA or fibronectin (Fig 5, F) or at day 5 after wounding in Stat6VT mice treated with ointment alone or ointment containing fibronectin (Fig, 5 G) . Data represent means of 2 independent experiments. *P < .05. Scale bar 5 200 mm. Pictures are representative of 3 mice from 2 independent experiments. wound healing. Stat6VT mice overexpress an active form of STAT6 in T cells, resulting in predominant T H 2-type cytokine production and allergic skin inflammation. 17, 27 Importantly for these studies, Stat6VT expression was observed in CD45 1 cells but not CD45
2 cells isolated from the dermis and epidermis of transgenic mice and was predominantly observed in CD4 1 cells (see Fig E4 in this article' s Online Repository at www.jacionline.org).
To investigate the re-epithelialization process in an atopic environment, we used an ear punch (2 mm in diameter) to wound ears of 4-to 6-month-old WT, Stat6VT, and Il4 2/2 Stat6VT mice (Fig 4, A) . It is important to note that there is no difference in the appearance of skin before wounding (Fig 4, B) . Through histologic analysis over 6 days after wounding, we monitored lesion reepithelialization and wound closure. At day 1 after wounding, wounds in all groups of mice exhibited a neutrophilic infiltrate (Fig 4, C) . At this time point, only WT and Il4 2/2 Stat6VT mice showed a denser epidermis at the wound border (Fig 4,  C) . Further analysis in the control group (ie, at days 3 and 6) showed a reduction in cellular infiltration and continuous reepithelialization. In contrast, Stat6VT mice exhibited pronounced tissue inflammation associated with edema and delayed wound closure (Fig 4, C) .
Ear sections were stained by means of immunofluorescence with the Ki-67 nuclear protein expressed during cell proliferation to determine whether differences in wound healing in WT, Stat6VT, and Il4 2/2 Stat6VT mice correlate with poor epithelial proliferation (Fig 4, D) . At all time points, all mice exhibited Ki-67 1 cells in the dermis and epidermis. However, WT and Il4
2/2
Stat6VT mice showed more intense staining in the epidermis mainly at days 1 and 3 after skin punch when compared with Stat6VT mice. At day 3, proliferative cells circumscribed most of the lesion in WT mice, and at day 6, the intensity of Ki-67 stain was attenuated. Stat6VT mice exhibited delayed epidermal proliferation and inefficient lesion closure. WT and Stat6 2/2 mice were treated with the vitamin D analog (MC903) for 5 days before wounding to verify whether deficient re-epithelialization also occurs in an induced model of AD-like disease and to determine whether IL-4 signaling normally regulates this process. Wound healing was monitored at days 3 and 6 after punch, and wound closure was measured by using morphometric analysis. We observed a significant decrease in wound closure at day 3 in MC903-treated WT mice compared with that seen in control mice treated with ethanol alone (see Fig E5, A and B, in this article's Online Repository at www.jacionline.org). Moreover, Stat6 2/2 mice exhibited earlier re-epithelialization when compared with WT mice treated with MC903 (see Fig E5, A and B) . Thus in models of induced and spontaneous AD, an atopic environment worsens re-epithelialization and wound-healing responses in the skin.
Topical fibronectin enhances skin wound healing in Stat6VT mice
T H 2-type cytokines can promote profibrotic pathways involved in tissue regeneration through induction of alternatively activated (M2) macrophage differentiation. 29 However, in our model the IL-4/STAT6 axis decreases skin wound healing. To explore this apparent contradiction, we tested the expression of cytokines and M2 markers in WT and Stat6VT intact ears (0 hour) and 3 and 24 hours after wounding. We observe that Arg1 (arginase) Retnla (Fizz1), and Chi3l3 (Ym1) mRNA levels were significantly increased at 0 hours in Stat6VT mice (Fig 5, A) when compared with WT mice. Expression of Il4, Arg1, and Retnla was increased at 3 and 24 hours after wounding in WT mice but did not reach the levels observed in transgenic mice. Additionally, we observed that Fn1 mRNA expression was similar at 0 hours in WT and Stat6VT mice (Fig 5, A) . However, at 3 hours after wounding, tissue from WT mice showed an increase in fibronectin expression and tissue from Stat6VT mice exhibited a significant reduction in Fn1 mRNA expression when compared with that in intact ears or WT mice (Fig 5, A) . Likewise, Il4 mRNA levels are increased and Fn1 mRNA levels are decreased in nonlesional and lesional skin from Stat6VT mice compared with levels seen in intact skin from WT mice (Fig 5, B) . Additionally, fibronectin levels measured by means of ELISA were significantly lower in the epidermis of Stat6VT mice at 24 hours after wounding when compared with samples from WT mice (Fig 5, C) .
Because fibronectin production was reduced in HK cultures after IL-4 stimulation and because this protein increased IL-4-stimulated HK scratch closure, we next determined whether topical application of fibronectin accelerates wound healing in allergic mice. WT and Stat6VT mice were treated with ointment containing 10 mg of BSA or fibronectin right after (day 1) and 24 hours after (day 2) wounding to test the involvement of fibronectin in the Stat6VT mouse wound-healing response. Histologic analyses were performed at day 3, a period when partial re-epithelialization was observed (Fig 4, C) . Macroscopic analysis revealed fibronectin treatment improved tissue recovery and erythema surrounding the lesion (Fig 5, D) . In histologic analysis (Fig 5, E) and morphometric analysis (Fig 5, F) topical fibronectin treatment significantly improved wound closure in Stat6VT mice compared with that seen in control protein-treated mice but had modest effects on WT mice. We also observed that fibronectin significantly increased wound closure in Stat6VT mice at day 5 after wounding when compared with that seen in Stat6VT mice receiving ointment alone as control (Fig 5, G) . Thus although IL-4 affects the expression of various genes directly involved in response to wounding, the IL-4-dependent repression in fibronectin expression appears to be a major target in contributing to the reduction of wound-healing potential of keratinocytes in an allergic environment.
DISCUSSION
IL-4 promotes the development of atopic diseases through effects on multiple cell types. Despite its critical role in AD, how IL-4 alters gene expression in keratinocytes has not been completely defined. In this report we use high-throughput transcriptomic analysis to identify IL-4-induced changes in keratinocyte gene expression at early and late stages of differentiation. Acute and chronic IL-4 stimulation resulted in extensive changes in gene expression profiles that spanned a variety of functional modules, including wound healing, a biological response impaired by IL-4. Moreover, central for IL-4-mediated effects in delayed wound healing was reduction in fibronectin production.
IL-4 alters a number of biological processes in keratinocytes, and cells in different stages of differentiation showed changes in distinct functions. Acute IL-4 stimulation (3 and 24 hours) resulted in alterations in genes involved in cell growth and survival and diminished expression of genes involved in cell adhesion, which together might contribute to epidermal hyperplasia, spongiosis, and diminished barrier function, all characteristics of lesional skin of patients with AD. [30] [31] [32] At day 5 of differentiation, IL-4 increased expression of genes involved in J ALLERGY CLIN IMMUNOL VOLUME 139, NUMBER 1 cell projection and adhesion and decreased expression of genes participating in response to wounding and defense. In fact, a subset of genes in IL-4-stimulated differentiated HKs (day 5) was similar in expression to less differentiated HKs (day 2). These changes might favor a less organized epithelial structure and contribute to an increased susceptibility to infection, which are also characteristics of AD lesions. 33, 34 Although most of the experiments used immortalized HKs and these might not entirely replicate intact skin, similar responses were observed with primary keratinocytes and skin equivalents made with primary cells. Moreover, several genes induced by IL-4, including CCL26, S100A7, S100A12, IL12RB, LCE3E, SERPINB3, SERPINB4, and ADAMTS4, were also increased in skin from patients with AD, 35, 36 indicating a possible role for IL-4 in mediating many skin barrier abnormalities in patients with AD.
Intense pruritis is a characteristic and often debilitating feature of AD, causing patients to scratch and consequently wound their skin. 37 Lesions are frequently associated with areas that patients readily reach to scratch. 38, 39 As our data indicate, IL-4 exposure might also contribute to AD pathogenesis by impairing appropriate wound repair. Using scratching of keratinocyte monolayers and time-lapse video microscopy, we demonstrate a significant decrease in recovery of the monolayer after IL-4 exposure. This observation could be linked to reports that children with AD demonstrating greater atopic responses had increased healing time of lesions. 28 In contrast to the wound-healing process observed here, recovery of barrier function after tape stripping of nonlesional skin in patients with AD and healthy control subjects was similar. 40 de Koning et al 41 reported no differences in gene expression between tape-stripped nonlesional skin of patients with AD versus skin from healthy control subjects, suggesting that decreased wound healing would most likely be observed in skin with a wound more severe than superficial tape stripping or in skin with an active inflammatory response.
IL-4 has been shown previously to be a prohealing cytokine in wound repair. 29, [42] [43] [44] [45] Our studies differ from these studies in several ways. First, we are focusing on re-epithelialization of the skin, rather than fibrosis and repair below the keratinocyte layers. We observed diminished re-epithelialization in 2 models of AD-like skin inflammation, and impaired healing was not observed when mice had defects in IL-4 signaling, suggesting this is a consistent effect of a proatopic environment. Importantly, we did not observe any defects in collagen deposition in the dermis during healing (data not shown).
Second, the IL-4 induced during wound repair in WT mice is much less than observed in atopic models. We directly demonstrated that M2 gene expression, a common target of IL-4 in woundhealing studies, is already greater before wounding in skin from ''atopic'' mice. Moreover, induction of these genes is increased in the skin of atopic mice. Together, these observations support a model wherein a low level of IL-4, functioning particularly in the dermis, is important for a healing response. However, in an atopic environment IL-4 is at sufficiently high concentrations to alter keratinocyte function and dermal M2 gene expression. In this respect it is not clear that the effects of IL-4 on fibronectin production are strictly on keratinocytes. In our analyses we observed diminished fibronectin protein levels in both the dermis and epidermis, suggesting that other cells might be affected by IL-4 in a similar fashion. Still, the in vivo results are consistent with the in vitro keratinocyte cultures, demonstrating an important contribution of keratinocyte-produced fibronectin in re-epithelialization.
It is difficult to separate the direct effects of IL-4 in these models versus the effect of IL-4-dependent inflammation in AD models. We observed that there was greater loss of fibronectin expression in lesional than nonlesional skin of Stat6VT mice. However, there was also greater Il4 expression in lesional skin, demonstrating that these factors are linked. Although the in vivo phenotype is consistent with the in vitro observations of keratinocyte function, we cannot exclude a contribution of additional cell types in vivo that are responding to IL-4 and mediating some of the delayed healing through secondary effects.
Although IL-4 modifies many genes involved in the wound response, 42 decreased fibronectin expression directly contributed to the in vitro impairment of HK monolayer wound closure. Fibronectin is a multidomain protein component of the extracellular matrix that is expressed in high levels at wound sites. 46, 47 It is associated with wound repair through, among other mechanisms during injury, enhancing growth factor binding stability and cell survival. 48, 49 Although topical application of fibronectin in lesions of Stat6VT mice only partially restored reepithelialization, this protein significantly improved the appearance of lesions, including decreasing erythema in the tissue. Many functions regulated by fibronectin, including adhesion, migration, and differentiation, 50 were also functions affected in HKs after IL-4 stimulation. Thus whether fibronectin can be used to treat AD lesions or other biological defects induced by IL-4 in keratinocytes is an interesting question remaining to be investigated.
Together, our findings describe a comprehensive role for IL-4 in preventing keratinocyte maturation by influencing the expression of key genes affecting skin barrier function. Induction of a subset of genes by IL-4 was confirmed in skin equivalents, and a deficient response of keratinocytes from allergic mice to wounding was also observed in vivo, further supporting a physiologic role for these studies. The more detailed understanding of IL-4-regulated genetic programs in keratinocytes described in this report should lead to additional insights into the development of allergic skin disease. (Fig E2,  A) or in HKs differentiated for 5 days with the indicated concentration of IL-4 (Fig E2, B) . C, HKs were differentiated with calcium chloride and stimulated with IL-4 or IL-13 for 2 or 5 days before analysis of gene expression. Data represent mean 6 SEM of 2 independent experiments. *P < .05 and **P < .01. (Fig E4, B) and in CD4 (Fig E4, C) through FLAG-tag antibody (solid gray line, WT mice; red line, Stat6VT mice). D and E, FLAG-tag mean fluorescence intensity in CD45 1 and CD452 cells in the epidermis and dermis (Fig E4, D) and in lymphocytes in spleens from WT and Stat6VT mice (Fig E4, E) . Data represent mean 6 SEM of 2 independent experiments. *P < .05.
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